This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brenchley, J. M.
Right arrow Articles by Douek, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brenchley, J. M.
Right arrow Articles by Douek, D. C.

 Previous Article  |  Next Article 

Journal of Virology, July 2006, p. 6801-6809, Vol. 80, No. 14
0022-538X/06/$08.00+0     doi:10.1128/JVI.00070-06

Preferential Infection Shortens the Life Span of Human Immunodeficiency Virus-Specific CD4+ T Cells In Vivo

Jason M. Brenchley,1 Laura E. Ruff,1 Joseph P. Casazza,2 Richard A. Koup,2 David A. Price,1 and Daniel C. Douek1*

Human Immunology Section,1 Immunology Laboratory, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland2

Received 10 January 2006/ Accepted 1 April 2006

CD4+ T-cell help is essential for effective immune responses to viruses. In human immunodeficiency virus (HIV) infection, CD4+ T cells specific for HIV are infected by the virus at higher frequencies than other memory CD4+ T cells. Here, we demonstrate that HIV-specific CD4+ T cells are barely detectable in most infected individuals and that the corresponding CD4+ T cells exhibit an immature phenotype compared to both cytomegalovirus (CMV)-specific CD4+ T cells and other memory CD4+ T cells. However, in two individuals, we observed a rare and diametrically opposed pattern in which HIV-specific CD4+ T-cell populations of large magnitude exhibited a terminally differentiated immunophenotype; these cells were not preferentially infected in vivo. Clonotypic analysis revealed that the HIV-specific CD4+ T cells from these individuals were cross-reactive with CMV. Thus, preferential infection can be circumvented in the presence of cross-reactive CD4+ T cells driven to maturity by coinfecting viral antigens, and this physical proximity rather than activation status per se is an important determinant of preferential infection based on antigen specificity. These data demonstrate that preferential infection reduces the life span of HIV-specific CD4+ T cells in vivo and thereby compromises the generation of effective immune responses to the virus itself; further, this central feature in the pathophysiology of HIV infection can be influenced by the cross-reactivity of responding CD4+ T cells.


* Corresponding author. Mailing address: VRC, NIH, Bldg. 40, Rm. 3509, 40 Convent Drive, Bethesda, MD 20892. Phone: (301) 594-8484. Fax: (301) 480-2565. E-mail: ddouek{at}mail.nih.gov.


Journal of Virology, July 2006, p. 6801-6809, Vol. 80, No. 14
0022-538X/06/$08.00+0     doi:10.1128/JVI.00070-06




This article has been cited by other articles:

  • Sacha, J. B., Giraldo-Vela, J. P., Buechler, M. B., Martins, M. A., Maness, N. J., Chung, C., Wallace, L. T., Leon, E. J., Friedrich, T. C., Wilson, N. A., Hiraoka, A., Watkins, D. I. (2009). Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection. Proc. Natl. Acad. Sci. USA 106: 9791-9796 [Abstract] [Full Text]  
  • Price, D. A., Asher, T. E., Wilson, N. A., Nason, M. C., Brenchley, J. M., Metzler, I. S., Venturi, V., Gostick, E., Chattopadhyay, P. K., Roederer, M., Davenport, M. P., Watkins, D. I., Douek, D. C. (2009). Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection. JEM 206: 923-936 [Abstract] [Full Text]  
  • Brenchley, J. M., Paiardini, M., Knox, K. S., Asher, A. I., Cervasi, B., Asher, T. E., Scheinberg, P., Price, D. A., Hage, C. A., Kholi, L. M., Khoruts, A., Frank, I., Else, J., Schacker, T., Silvestri, G., Douek, D. C. (2008). Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112: 2826-2835 [Abstract] [Full Text]  
  • Veazey, R. S., Acierno, P. M., McEvers, K. J., Baumeister, S. H. C., Foster, G. J., Rett, M. D., Newberg, M. H., Kuroda, M. J., Williams, K., Kim, E.-Y., Wolinsky, S. M., Rieber, E. P., Piatak, M. Jr., Lifson, J. D., Montefiori, D. C., Brown, C. R., Hirsch, V. M., Schmitz, J. E. (2008). Increased Loss of CCR5+ CD45RA- CD4+ T Cells in CD8+ Lymphocyte-Depleted Simian Immunodeficiency Virus-Infected Rhesus Monkeys. J. Virol. 82: 5618-5630 [Abstract] [Full Text]  
  • Mooij, P., Balla-Jhagjhoorsingh, S. S., Koopman, G., Beenhakker, N., van Haaften, P., Baak, I., Nieuwenhuis, I. G., Kondova, I., Wagner, R., Wolf, H., Gomez, C. E., Najera, J. L., Jimenez, V., Esteban, M., Heeney, J. L. (2008). Differential CD4+ versus CD8+ T-Cell Responses Elicited by Different Poxvirus-Based Human Immunodeficiency Virus Type 1 Vaccine Candidates Provide Comparable Efficacies in Primates. J. Virol. 82: 2975-2988 [Abstract] [Full Text]  
  • Giraldo-Vela, J. P., Rudersdorf, R., Chung, C., Qi, Y., Wallace, L. T., Bimber, B., Borchardt, G. J., Fisk, D. L., Glidden, C. E., Loffredo, J. T., Piaskowski, S. M., Furlott, J. R., Morales-Martinez, J. P., Wilson, N. A., Rehrauer, W. M., Lifson, J. D., Carrington, M., Watkins, D. I. (2008). The Major Histocompatibility Complex Class II Alleles Mamu-DRB1*1003 and -DRB1*0306 Are Enriched in a Cohort of Simian Immunodeficiency Virus-Infected Rhesus Macaque Elite Controllers. J. Virol. 82: 859-870 [Abstract] [Full Text]  
  • Alvarez, R., Reading, J., King, D. F. L., Hayes, M., Easterbrook, P., Farzaneh, F., Ressler, S., Yang, F., Rowley, D., Vyakarnam, A. (2008). WFDC1/ps20 Is a Novel Innate Immunomodulatory Signature Protein of Human Immunodeficiency Virus (HIV)-Permissive CD4+ CD45RO+ Memory T Cells That Promotes Infection by Upregulating CD54 Integrin Expression and Is Elevated in HIV Type 1 Infection. J. Virol. 82: 471-486 [Abstract] [Full Text]  
  • Duvall, M. G., Lore, K., Blaak, H., Ambrozak, D. A., Adams, W. C., Santos, K., Geldmacher, C., Mascola, J. R., McMichael, A. J., Jaye, A., Whittle, H. C., Rowland-Jones, S. L., Koup, R. A. (2007). Dendritic Cells Are Less Susceptible to Human Immunodeficiency Virus Type 2 (HIV-2) Infection than to HIV-1 Infection. J. Virol. 81: 13486-13498 [Abstract] [Full Text]  
  • Holmes, D., Knudsen, G., Mackey-Cushman, S., Su, L. (2007). FoxP3 Enhances HIV-1 Gene Expression by Modulating NF{kappa}B Occupancy at the Long Terminal Repeat in Human T Cells. J. Biol. Chem. 282: 15973-15980 [Abstract] [Full Text]  
  • Tilton, J. C., Luskin, M. R., Johnson, A. J., Manion, M., Hallahan, C. W., Metcalf, J. A., McLaughlin, M., Davey, R. T. Jr., Connors, M. (2007). Changes in Paracrine Interleukin-2 Requirement, CCR7 Expression, Frequency, and Cytokine Secretion of Human Immunodeficiency Virus-Specific CD4+ T Cells Are a Consequence of Antigen Load. J. Virol. 81: 2713-2725 [Abstract] [Full Text]  
  • Kinter, A., McNally, J., Riggin, L., Jackson, R., Roby, G., Fauci, A. S. (2007). Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals. Proc. Natl. Acad. Sci. USA 104: 3390-3395 [Abstract] [Full Text]